COP
36
2
CHRW
53
2
NDAQ
46
2
WU
26
2
STT
48
4
KIM
58
2
DRI
74
5
RRC
52
2
EXR
42
5
LRCX
56
4
NRG
32
5
WAT
55
11
MS
64
3
D
32
10
AES
47
4
EMR
57
7
MDLZ
28
2
EQIX
59
2
HOG
29
4
JNPR
59
3
COP
36
2
CHRW
53
2
NDAQ
46
2
WU
26
2
STT
48
4
KIM
58
2
DRI
74
5
RRC
52
2
EXR
42
5
LRCX
56
4
NRG
32
5
WAT
55
11
MS
64
3
D
32
10
AES
47
4
EMR
57
7
MDLZ
28
2
EQIX
59
2
HOG
29
4
JNPR
59
3
Financhill
Back

Dyne Therapeutics 10K Form

Sell
20

DYN
Dyne Therapeutics

Last Price:
$23.99
Seasonality Move:
12.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DYN News And Ratings

See the #1 stock for the next 7 days that we like better than DYN

DYN Financial Statistics

Sales & Book Value

Annual Sales: $4.8B
Cash Flow: $-74.9M
Price / Cash Flow: 0
Annual Sales: $6.93
Price / Book: 3.46

Profitability

EPS (TTM): -3.56000
Net Income (TTM): $-294.5M
Gross Margin: $1.9B
Return on Equity: 0%
Return on Assets: 0%

Dyne Therapeutics Earnings Forecast

Key Dyne Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 13 years for DYN is 39.45%.
  • The Selling, General & Administrative Expenses for DYN have been equal to 3.90% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Dyne Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DYN
CUSIP: 26818M
Website: dyne-tx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DYN Technical Analysis vs Fundamental Analysis

Sell
20
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy or a Sell?

  • Dyne Therapeutics stock is rated a Sell
    The current Dyne Therapeutics [DYN] share price is $23.99. The Score for DYN is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.